New AI solution brings authorization, clinical and progress data into one review-ready draft, giving BCBAs more time to focus on clinical decision-making

FORT LAUDERDALE, Fla., Sept. 22, 2026 /PRNewswire/ -- CentralReach, a leading provider of autism and intellectual and developmental disabilities (IDD) care software, today announced the general availability of ReportDraftAI, an AI-assisted product that streamlines reporting from initial draft through review and sign-off, bringing authorization, clinical and progress data already maintained in CentralReach into a structured, review-ready draft. By reducing the manual work of finding, transferring and assembling information, ReportDraftAI helps Board Certified Behavior Analysts (BCBAs) spend more of their time on the clinical interpretation and decision-making only they can provide.

A Growing "Burden of Proof" in Autism and IDD Care

Providers in this field are no longer just expected to deliver quality care — they're expected to continuously prove it, through documentation and audits that keep pace with evolving regulations. That burden falls hardest on BCBAs: a 2025 study in Behavior Analysis in Practice found behavior analysts spend approximately 46% of their time on indirect, non-billable activities like reporting, data analysis and treatment plan development — nearly double the 25–30% that clinical guidelines recommend for that work. It's a leading driver of the burnout destabilizing the field, with 72% of ABA practitioners reporting medium-to-high burnout tied to documentation load.

Reauthorization reporting is a clear example of that burden. At least twice a year for every learner, BCBAs must bring together authorization information, clinical data, progress toward goals, assessments and other information to demonstrate medical necessity and ensure care can continue without disruption. Start to finish, the full process typically takes 9-12 hours, much of it in non-billable time. While clinical analysis and decision-making are essential BCBA work, finding information, transferring data and assembling the report are administrative tasks that consume valuable time.

From Data Aggregation to Report Completion

ReportDraftAI streamlines the reporting workflow from initial draft through review and sign-off, while keeping the BCBA in control of every clinical decision. The clinician selects the learner, report template and authorization or reporting period, and ReportDraftAI pulls available information already maintained in CentralReach into a structured, review-ready draft. Authorization, service, clinical, target-level and assessment information are brought together in one place, reducing the need to manually find, copy, and transfer data across the learner record.

From there, the clinician reviews the content, applies clinical interpretation, documents medical necessity, and adds recommendations. Built-in comments and review workflows support collaboration and revisions with peers, while signature functionality for BCBAs, supervisors, and caregivers helps move the report toward completion. Once finalized the report can be published directly from CentralReach.

"What excites me about ReportDraftAI is that it takes on the administrative work without taking away clinical autonomy. BCBAs should be spending their time on the clinical work only they can do, developing goals, supporting their teams and being present with their patients, said Emily Doak, Chief Compliance Officer at Bloomwell Autism Therapy. "ReportDraftAI gives clinicians a strong starting point, while the review and approval process ensures they remain firmly in control of the clinical decisions and final report."

Part of a Growing Suite of Clinical AI Products

ReportDraftAI is the latest addition to CentralReach's growing lineup of clinical AI tools built to address provider documentation burden end to end:

- NoteDraftAI, which drafts RBT session notes, has assisted more than 5.8 million session note summaries drafted to date, at a daily cadence of 37,000, with RBTs saving an average of 8 hours per week on session note writing.

- NoteGuardAI, which audits notes and claims against payer and regulatory requirements before submission, now audits 100,000 notes per day. In August 2026 alone, NoteGuardAI processed more than 3 million notes across over 400 organizations, catching failures that put $165 million in revenue at risk.

"Our focus is on ensuring that BCBAs are able to spend their time interpreting clinical data and making decisions about care, not copying information from one place to another," said Peter Boumenot, Chief Product Officer at CentralReach. "ReportDraftAI is designed to take on that administrative burden across the reporting workflow, from assembling information and creating a first draft through review and sign-off, while keeping the clinician firmly in control of the clinical interpretation, medical necessity and final report."

What's Next: VoiceDraftAI

CentralReach also announced that VoiceDraftAI, its next Clinical AI documentation product, has moved into beta. VoiceDraftAI's voice-to-structured-documentation capability is designed to give ABA and IDD clinicians back time spent on narrative documentation. Clinicians speak naturally, and VoiceDraftAI uses AI to identify, tag, and populate the relevant fields within the Learner's chart, turning dictation into compliant and structured records for incidents, supervision, and intake workflows. Like the rest of CentralReach's Clinical AI suite, VoiceDraftAI is human-in-the-loop, off by default and admin-controlled. Customers attending CR Unite 2026 (September 21-23, Boston) will get priority access to the expanding beta.

About CentralReach

CentralReach is a leading provider of autism and IDD care software, providing a complete, end-to-end software and services platform that helps children and adults diagnosed with autism spectrum disorder (ASD) and related intellectual and developmental disabilities (IDD) - and those who serve them - unlock potential, achieve better outcomes, and live more independent lives. With its roots in Applied Behavior Analysis, the company is revolutionizing how the lifelong journey of autism and IDD care is enabled at home, school, and work with powerful and intuitive solutions purpose-built for each care setting, trusted by more than 200,000 professionals globally, CentralReach is committed to ongoing product advancement, market-leading industry expertise, world-class client satisfaction, and support of the autism and IDD community to propel autism and IDD care into a new era of excellence. For more information, please visit CentralReach.com or follow us on LinkedIn.

SOURCE CentralReach

Share this article

Companies aim to combine blood-based circRNA biomarkers of disease biology and pathology with objective digital measures of cognition and function, to accelerate Alzheimer's drug development today and create a scalable frontline care tomorrow.

SAN DIEGO and WASHINGTON, Sept. 22, 2026 /PRNewswire/ -- Circular Genomics and Altoida today announced a collaboration combining Circular Genomics' blood-based circular RNA (circRNA) biomarker platform with Altoida's AI-powered Digital NeuroMarker™ platform. The alliance is designed to advance an integrated biology-and-function approach to Alzheimer's drug development and frontline healthcare by creating a first-of-kind, multimodal approach to improve early identification, patient stratification and longitudinal monitoring in Alzheimer's disease (AD).

The collaboration brings together two complementary technologies that measure distinct aspects of disease etiology: blood-based molecular signatures of neurodegeneration and disease progression and objective digital measures of cognitive function. Together, the companies intend to demonstrate a new frontline diagnostic paradigm that combines objective measures of digital cognitive function and disease biology.

The integrated approach is designed to create a scalable and efficient digital-first pathway that assesses cognitive function followed by a confirmatory disease biology and pathology blood test . This pathway fits naturally into routine clinical workflows, reduces reliance on specialist-based assessment, and enables earlier interventions when they can have the greatest impact. As part of the collaboration, the companies plan to conduct real-world evidence studies evaluating the combined workflow in clinical research and frontline care settings, with the first pilots expected to launch later this year.

As the Alzheimer's therapeutic landscape shifts toward earlier intervention, the ability to identify individuals at risk before irreversible neurodegeneration has occurred is becoming one of the defining challenges in healthcare. The arrival of disease targeting therapies is reshaping Alzheimer's care. Yet most patients are still diagnosed too late because current diagnostic pathways remain fragmented, specialist-dependent, and difficult to scale.

By combining molecular evidence of neurodegeneration with rapid and sensitive measures of functional change, the collaboration aims to generate evidence for a practical frontline workflow in which a 10-minute, self-administered objective cognitive function assessment can be completed before a circRNA blood biomarker testing is ordered to confirm disease biology. This approach is designed to help reduce reliance on subjective specialist-based neuropsychological batteries that can take hours, streamline referral and treatment decisions, expand specialist capacity, monitor treatment effectiveness more objectively, and extend access beyond specialty neurology and memory clinics and into primary care].

The announcement follows the publication of Circular Genomics' Nature Medicine study demonstrating that a blood-based circRNA signature predicts progression to symptomatic Alzheimer's disease years before clinical onset and provides information complementary to established amyloid and tau biomarkers. It also builds on Altoida's growing body of peer-reviewed research, including its recently published study in Alzheimer's and Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) demonstrating that the Digital NeuroMarker Platform can accurately detect mild cognitive impairment though a brief self-administered digital assessment, and, when deployed before blood biomarker testing, complements molecular diagnostics while improving the overall performance of a scalable frontline Alzheimer's diagnostic workflow. Altoida is now preparing to initiate a pivotal study intended to support FDA clearance of the Digital NeuroMarker Platform for use across healthcare settings.

"The future of Alzheimer's detection and precision neurology will not be built around a single biomarker; but on combining complementary biological signals with cognitive function assessment. Our CircPath™ platform provides a fundamentally new window into the biology of neurodegeneration, and together with Altoida's digital phenotyping capabilities we believe we can help accelerate therapeutic development while moving the field toward more personalized care earlier in the disease process." Said Paul Sargeant, CEO Circular Genomics.

"Biology and function answer different but essential questions: which biological disease pathways are occurring and how are they affecting the individual patient in everyday life", said Marc Jones, CEO Altoida, "By studying them together, we aim to help drug developers enrich trials, stratify patients and measure change more precisely today, while generating the evidence required for a scalable frontline health care tomorrow."

Together, Circular Genomics and Altoida aim to establish a new multimodal model for precision neurology: improving Alzheimer's drug development today while enabling a future with a more scalable and efficient patient care path.

About Circular Genomics

Circular Genomics is the precision neurology leader pioneering circular RNA (circRNA) technology to develop next-generation molecular blood biomarker diagnostics. Leveraging the unique stability, brain enrichment, and biological relevance of circRNAs, the company is advancing a differentiated platform of blood-based tests designed to provide comprehensive, pathway-level insight into disease biology—with an initial focus on neurodegenerative disorders including Alzheimer's disease. Circular Genomics' proprietary circRNA platform (CircPath™) is positioned to address critical unmet needs in early disease detection, patient stratification, and therapeutic development support, creating strategic value for healthcare systems, pharmaceutical partners, and patients.

About Altoida

Altoida is defining a new category in neurological care with a first-of-its-kind, AI- and AR-powered digital biomarker platform for clinical-grade cognitive and functional assessment. The company's 10-minute, self-administered Digital NeuroMarker Platform captures millions of raw multimodal data points across motor, speech, and cognitive domains, designed to enable earlier and more objective detection of Mild Cognitive Impairment (MCI) and Alzheimer's disease. Built on 20+ years of scientific research and tens of thousands of tests across more than 20,000 participants in academic, research, and global pharma trials, Altoida's Digital NeuroMarker Platform has been independently researched and peer-reviewed in Nature Digital Medicine. With an estimated 200M undiagnosed MCI patients worldwide, many of whom are eligible for new Alzheimer's drugs, patients, payors and providers are demanding scalable solutions. With billing codes available, treatments on the market and more emerging, Altoida is uniquely positioned to meet this $7B+ near-term market and to empower clinicians to deliver earlier interventions when they matter most. Altoida's NeuroMarker platform is currently intended for investigational use only and has not received FDA clearance or approval and is not available for commercial sale.

SOURCE Circular Genomics

Share this article

Wild Alaska Sole packs complete protein, omega-3s and other essential nutrients into one lean, versatile fish

SEATTLE, Sept. 22, 2026 /PRNewswire/ -- Protein is having a moment. The newest Dietary Guidelines for Americans just put whole foods and high-protein eating front and center, and shoppers are paying attention – not just to how much protein is on their plate, but where it comes from. Enter Wild Alaska Sole: a mild, versatile whitefish from the pristine waters of Alaska – often labeled as Wild Alaska Flounder in the U.S. It's a complete protein source, delivering 26g per 3.5-ounce serving, all in a low-calorie, low-fat package. Here's what makes it one of the smartest protein choices in the grocery store.

Whole Food, Complete Protein

When it comes to protein, it's not just about quantity. The source matters, too. As shoppers focus more on protein intake, whole food sources are getting more attention. Many high-protein products in stores rely on soy and vegetable isolates, while whole foods contain high-quality protein in its natural form, along with other naturally occurring nutrients. Wild Alaska Sole is one of those whole food sources of complete protein, meaning it contains all nine essential amino acids, which the body can only get from food. There's real value in choosing whole foods over processed alternatives, including supporting a healthy gut biome, boosting the immune system, and reducing the risk of chronic diseases.

"Twenty-six grams of complete protein, all nine essential amino acids, and nothing processed along the way. At a time when so many high-protein food products are highly processed, Wild Alaska Sole is proof that whole, wild-caught fish already does the job," said Pat Shanahan, executive director of the Wild Alaska Sole Association. "Most shoppers have never heard of Wild Alaska Sole, and that's exactly the gap we're working to close. This is a protein that's been quietly available in the freezer aisle for years, delivering more nutrition than most people expect. We want people to know it's there, ready to support their health goals."

Nutrition that Delivers

Beyond protein, Wild Alaska Sole delivers a dense, well-rounded nutrition profile in a single 3.5-ounce serving:

- 665 mg of omega-3s (EPA + DHA): Essential fatty acids for brain, heart and eye health.

- 11 mcg of vitamin B-12: Supports cellular energy production, DNA synthesis, and nervous system health.

- 32 mcg of selenium: Mineral that maintains thyroid function, bone health, and immune defense.

- 300 mg of potassium: Essential mineral that contributes to heart health by helping regulate blood pressure and reduce stroke risk.

- 212 mg of phosphorus: Key mineral essential for strong bones and teeth, kidney function, muscle contraction, and nerve signaling.

- 104 calories and 26g of protein: Wild Alaska Sole provides high protein value with fewer calories, when compared to more popular proteins like chicken or beef.

Healthy Habits on Hand

One of the secrets to sticking to healthy eating habits is making the healthy choice the easy choice. Wild Alaska Sole fillets (also sold as flounder in the U.S.) are high-value and widely available in the freezer section of most major grocery stores nationwide. The thin fillets thaw quickly – and can even be cooked frozen. Whether pan-seared, baked, poached, steamed, or air-fried, it's perfectly cooked in just 3-7 minutes. Wild Alaska Sole's simplicity and versatility make it easy to keep a nutritious, natural superfood on hand.

Celebrate the Season, Save at the Store

To celebrate National Seafood Month this October, many grocers across the country, including Publix and Giant Eagle, are offering great pricing on Wild Alaska Sole. It's a perfect time to enjoy the benefits of Wild Alaska Sole at an even more affordable price.

For more information on Wild Alaska Sole, recipes and answers to frequently asked questions, visit www.wildalaskasole.org.

About Wild Alaska Sole Association

The Wild Alaska Sole Association (WASA) is dedicated to increasing the awareness, appreciation, and value of Alaska flatfish. Representing the largest flatfish fishery in the world and the second largest federally managed fishery in Alaska, WASA is working to promote Wild Alaska Sole in major seafood markets globally by educating both seafood buyers and consumers about the superior benefits of Wild Alaska Sole. For more information, visit www.wildalaskasole.org or follow on Facebook, Instagram or LinkedIn.

SOURCE Wild Alaska Sole Association

Share this article

NORWALK, Conn., Sept. 22, 2026 /PRNewswire/ -- Heartwood Partners is pleased to announce that, on May 29, 2026, in partnership with the management team who will continue to lead the Company, it made a growth investment in The Xtreme Group ("TXG" or the "Company").

Headquartered in Miami, Florida, TXG has built a leading independent, full-service aviation MRO platform with capabilities spanning airframe heavy maintenance, engine MRO, line maintenance, aircraft on ground (AOG) services, and the sale and lease of aircraft and engines, serving primarily cargo and commercial operators. The Company serves a marquee customer base from its headquarters in Miami, Florida, with line maintenance stations across major U.S. airports.

"We are delighted to partner with Carlos and the entire TXG team as they enter this exciting next chapter of growth," said Ed Tan, Managing Partner, Heartwood Partners. "We first met Carlos at the annual MRO show, and we are proud to have fostered that relationship into today's partnership. TXG has built an exceptional reputation in aviation MRO through over a decade of consistent, high-quality execution for some of the industry's most demanding cargo and commercial operators. Heartwood's growth-oriented, low-leverage approach is well-suited to support TXG's expansion into new geographies, service lines, and additional capacity, and we look forward to partnering with Carlos and the team to accelerate that trajectory."

"The Xtreme Group exemplifies the type of founder-led, operationally excellent business that Heartwood is built to back," said James Jang, Managing Director, Heartwood Partners. "Carlos and the TXG team have created a differentiated platform in a large and growing MRO market, and we see significant opportunity to build on that foundation — both organically and through strategic add-on acquisitions. We are excited to bring Heartwood's full resources to bear in support of that vision."

"Since founding Xtreme Aviation in 2013, our singular focus has been on delivering the highest-quality MRO services to our customers — on time, on budget, and to the safety standards they demand," said Carlos Cock, Chief Executive Officer, The Xtreme Group. "Partnering with Heartwood marks an exciting new chapter for TXG. Their growth-oriented investment approach and in-house value creation capabilities give us the resources to expand our capacity, broaden our service lines, and extend our geographic reach — all while maintaining the quality and customer relationships that define who we are. We look forward to what we will build together."

About Heartwood Partners

Heartwood Partners, a middle market private equity firm, is differentiated by a unique lower-leverage, current cash yield approach designed to create partnership with continuing management. Our approach combines a conservative capital structure with strategic execution to support long-term growth, including organic and acquisition-driven expansion into new products, services, and end markets. In addition, we support each management team with our in-house Value Creation team who provide deep, subject-matter experience in strategic areas such as eCommerce and digital marketing, human capital and organizational design, IT improvement, and acquisition integration. We manage over $1.4 billion (as of 12/31/25) in investments and commitments, and our principals have invested in more than 100 platform and add-on acquisitions. Heartwood is currently investing from Heartwood Partners IV, LP, and is focused on founder, family and management-held businesses serving the building products, commercial and industrial services, distribution, environmental services, niche manufacturing, packaging, specialty chemicals/materials, food/agriculture/nutrition markets. For additional information about Heartwood, please visit www.heartwoodpartners.com.

About The Xtreme Group

The Xtreme Group (TXG) is a leading independent, full-service aviation MRO platform headquartered in Miami, Florida. Founded in 2013, TXG operates through three primary subsidiaries: Xtreme Aviation LLC, an FAA Part 145 certificated MRO provider delivering airframe maintenance, repair, modification, and line maintenance services across major U.S. airports; Ignite Aero Engines, specializing in CFM56 and CFM34 turbine engine MRO and overhaul services; and Aventus Air Leasing II, focused on the acquisition, refurbishment, and sale and leasing of aircraft and engines. TXG serves a global customer base of cargo, commercial, and charter operators. With a track record built on safety, quality, and on-time performance, TXG provides its airline and cargo customers with a comprehensive, single-source MRO solution. For more information, please visit www.txg.aero.

SOURCE Heartwood Partners

Share this article

Chestnut Nature Works builds upon Chestnut's broader platform, combining land expertise, community engagement, environmental stewardship, and project development to support the next generation of data center, energy, and industrial growth in the United States.

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- Chestnut today announced the launch of Chestnut Nature Works (CNW), a new business that helps developers, hyperscalers, utilities, investors, and communities create the environmental and community foundations necessary to accelerate responsible growth at the local level. CNW is a natural expansion of Chestnut's industry-leading nature-based carbon removal business.

As data center development and industrial growth accelerate across the United States, projects face increasing scrutiny from local stakeholders. Concerns often center on water availability, environmental impacts, community trust, and whether promised economic benefits will materialize.

CNW was created to turn those concerns into lasting commitments that deliver measurable local benefits, including restored watersheds, protected land, local jobs, and community assets. This helps America's communities welcome growth while preserving what makes them unique.

Chestnut believes successful projects require more than engineering and capital. They require authentic local engagement, visible community benefits, long-term stewardship, and transparency every step of the way. CNW gives the companies building America's next chapter a way to strengthen the land, water, and communities their projects depend on.

"The U.S. built its economic leadership through transformative investments in railroads, electrification, highways, and digital networks," said Brian DiMarino, Chief Commercial & Operating Officer, Chestnut. "Today's AI economy requires a new generation of investment, not only in data centers and power infrastructure, but also in the communities and natural infrastructure that supports them. Chestnut Nature Works exists to help ensure growth creates lasting local value."

Leveraging Chestnut's experience acquiring, managing, restoring, and developing natural assets across the United States for its flagship forest carbon projects, CNW combines strategic advisory services with implementation capabilities to move projects from concept through execution. The platform's services include watershed restoration, water replenishment initiatives, forestry and conservation projects, ecological buffers, community recreation assets, workforce partnerships, and stakeholder engagement programs designed to create visible and measurable local benefits. Chestnut's proprietary land screening and monitoring technologies help accelerate project development and ongoing stewardship efforts.

Unlike traditional consulting firms, CNW is designed as an execution-oriented platform capable of originating, structuring, and implementing projects at scale. Its team combines expertise in land management, forestry, conservation, project finance, and economic development with a network of partners. Through relationships with organizations across energy, utilities, engineering, environmental services, and institutional investment, CNW brings the capabilities and credibility required to address community-level concerns on large-scale projects.

"Major infrastructure projects succeed when communities, developers, utilities, and local stakeholders work together from day one," said Ben Dell, CEO, Chestnut and Managing Partner, Kimmeridge. "Our role is to help bring those groups together and deliver tangible outcomes that create value for everyone involved."

About Chestnut

Chestnut builds and manages natural infrastructure across the United States, restoring forests, watersheds, and working lands that deliver lasting ecological and economic benefits alongside verified carbon removal. Founded in 2022, the company combines land acquisition, project finance, forestry, and carbon market expertise to develop and operate projects at scale. For additional information on Chestnut, its strategies and environmental stewardship, please visit https://chestnutcarbon.com/.

SOURCE Chestnut

Share this article

Composition Wealth Deepens Leadership Team with Appointment of Gabrielle Glemann as General Counsel and CCO and Joe Salcido as Head of Advisors

Continued addition of industry veterans underscores rapidly expanding RIA's commitment to driving accelerated growth for financial advisors

LOS ANGELES, Sept. 22, 2026 /PRNewswire/ -- Composition Wealth, a national registered investment advisor (RIA) enterprise with over $12 billion in assets and 125 employees nationwide, have announced the appointment of Gabrielle Glemann in the dual role of General Counsel and CCO and Joe Salcido as Head of Advisors. Both Glemann and Salcido are industry leaders, each with 20 years of experience at prominent financial services firms.

Glemann will lead Composition Wealth's legal and compliance functions, partnering with executive leadership on governance, risk management and strategic growth. Salcido will be responsible for working closely with advisors to enable organic growth, while offering coaching and delivering practice management support.

Enhanced leadership team to strengthen high-energy firm's innovation

"Our unique value proposition as a true business partner and destination of choice for high-net-worth-focused financial advisors is resulting in great success, and our investment in high-quality executive talent reinforces our commitment to the growth of our firm and advisors," said Nate Angelo, CEO of Composition Wealth. "Gabrielle's and Joe's experience and perspectives not only enhance our management team, but better position us to execute on the next phase of our strategic expansion plans."

Founded in 2007, Composition Wealth offers a supportive, advisor-focused environment that fosters success through a true partnership.

The firm provides exceptional experience, advice, and technology tailored to enhance clients' overall financial success. Its integrated approach surrounds the advisor-client relationship with experts in investments, tax planning, estate strategies, and retirement planning to create comprehensive solutions for each client's needs.

Experience across the wealth management ecosystem

Glemann brings two decades of experience advising SEC-registered investment advisers, private fund managers and global investment platforms. She joins Composition Wealth from Cercano Management, a SEC-registered investment adviser, where she served as General Counsel and Partner.

Previously a Director of Legal & Compliance at BlackRock, Glemann supported the firm's global alternatives platform across hedge fund, private equity, direct, and co-investment strategies. Earlier in her career, she practiced at Stoel Rives LLP in Seattle and Hughes Hubbard & Reed LLP.

Salcido has more than 20 years of experience in sales, operations, and leadership within financial services. Before joining Composition Wealth, he spent nearly ten years at Edelman Financial Engines, most recently as Regional Director of Wealth Planning, where he led the southeast division of advisors.

Earlier in his career at Edelman, as Director of Sales, Salcido helped lead the organization through two major mergers and integrations, scaling the sales team to support the firm's continued growth. He began his career at Vanguard, spending more than a decade in progressively senior sales, trading, and operations leadership roles.

About Composition Wealth

Composition Wealth is a national RIA firm that aligns accomplished financial advisors and specialists with successful individuals, families, and business owners to reach their life and intergenerational goals. The firm is focused on providing exceptional experience, advice, and technology tailored to enhance clients' overall financial success. Its integrated approach surrounds the advisor-client relationship with experts in investments, tax planning, estate strategies, and retirement planning to create comprehensive solutions for each client's needs.

Founded in 2007 as Miracle Mile Advisors and headquartered in Los Angeles, the firm has team locations in Baltimore/DC, Chicago, Columbus, Ohio, New York, San Diego, San Francisco and Seattle.

For advisors seeking to write their next chapter with Composition Wealth, visit www.composition.com/for-advisors.

Media Contact

Elizabeth Shim / Donald Cutler

Haven Tower Group

424 317 4861 or 424 317 4864

[email protected] or [email protected]

SOURCE Composition Wealth

Share this article

CALGARY, AB, Sept. 22, 2026 /PRNewswire/ -- The village isn't gone. It's just really busy.

That's one of the key findings from Cashew's latest study, The Capacity Gap, which surveyed 2,002 adults across the U.S. and Canada.

The research reveals a tension at the heart of modern life: people still have family, friends and communities they can rely on, but increasingly lack the time, energy and capacity to turn that support into action. As a result, paid services are becoming part of the modern support system.

"People have always relied on one another, but the economics of time have changed," said Addy Graves, CEO of Cashew. "Convenience isn't just about getting something faster or easier. It's about creating capacity for caregiving, relationships, work and the things people can't outsource."

The support is there. The capacity isn't.

Consumers continue to report strong connections to the people around them. Seventy percent say they have a good emotional support system, while 67% say they feel connected to a community.

But that support doesn't always translate into practical help. Among adults under 45, 41% say paid services now handle things that family and friends once did, compared with 18% of adults aged 62–80.

Convenience is becoming a way to protect capacity

For many consumers, paying for help is about deciding where their limited time and energy matter most. By outsourcing everyday tasks, people can preserve capacity for the priorities they consider harder to replace.

That reframes convenience. It's no longer simply about saving time. It's about what that saved capacity makes possible.

Caregivers are feeling the gap most

The capacity gap is particularly visible among caregivers. Nearly two-thirds say they will pay for faster delivery when the person they care for needs something, even while cutting back on their own dining, entertainment and travel.

One-third say they have taken on debt to cover caregiving services, rising to 41% among caregivers aged 18–29.

For caregivers, paid services can move from convenience to necessity, helping them manage competing demands when there is simply too much to do.

What this means for brands

The opportunity is bigger than selling convenience. Brands can play a new role in the support system: creating capacity. The most relevant brands will understand what people want to keep doing themselves and help create the capacity to do it.

The full Capacity Gap study is available:

About Cashew

Cashew runs original research with real people on its own research platform, turning proprietary insights into distinctive strategies, stories and content for brands.

SOURCE Cashew Research

Share this article

GREENWICH, Conn., Sept. 22, 2026 /PRNewswire/ -- Hunt Scanlon Ventures, a leading M&A advisory firm focused on the human capital markets, announced today that it has completed an investment in millionways, a New York-headquartered frontier lab building a behavioral intelligence layer of AI.

millionways pioneered the development of a proprietary Large Psychology Model, Thorsten-4, designed to understand human signals, motives, communication patterns, and behavior. The platform has applications across AI governance, executive hiring, talent management, leadership assessment, and enterprise environments. The company is led by co-founders Martin Cordsmeier and Max Weidemann.

"millionways is a trailblazer in behavioral intelligence," said Scott A. Scanlon, CEO and co-founder of Hunt Scanlon Ventures. "As investors, we see behavioral intelligence as a new layer of AI infrastructure, giving artificial intelligence a missing layer—the ability to interpret the human dynamics behind communication and decision-making."

"The next leap in AI isn't another model that knows more. It's AI that understands people better," said Max Weidemann, co-founder and CTO of millionways. "We built millionways to give AI that missing layer: a scientifically grounded, explainable understanding of human motives, behavior and context. Hunt Scanlon immediately understood why that becomes critical as humans and AI agents increasingly work together."

The investment comes as artificial intelligence moves deeper into environments where decision quality, leadership, trust, and human interaction matter as much as workflow efficiency. For Hunt Scanlon Ventures, behavioral intelligence represents an opportunity to bring greater structure and intelligence to decisions that have historically depended heavily on observation, experience, and intuition.

Underlying Thorsten-4 is more than a decade of proprietary psychological research and development and 35 million tagged words of behavioral data. That scientific and data foundation supports millionways' ability to identify behavioral patterns and translate human interactions into structured, explainable intelligence.

The technology is already proven and validated in the human capital sector, with applications spanning executive hiring, leadership assessment, succession planning, talent management, and organizational decision-making. As humans increasingly work alongside intelligent agents, Hunt Scanlon believes the ability to understand motives, communication patterns, and behavioral context will become increasingly important to both talent decisions and broader enterprise performance.

"We see the ability to translate human behavior into actionable business intelligence as increasingly important across the human capital markets," said Mr. Scanlon. "Those are not small efficiency gains. Those are enterprise value levers."

For Hunt Scanlon Ventures, the investment also reflects a broader strategy of backing data-driven and AI-powered platforms positioned to reshape how organizations assess talent, evaluate leadership, and make critical business decisions.

"As foundational AI models become increasingly commoditized, the ability to understand the human context behind an interaction becomes more valuable, not less," said Mr. Scanlon. "Behavioral intelligence—and millionways' approach to the category—represents an important step in that evolution."

To learn more about millionways and its behavioral intelligence platform, visit millionways.ai.

About Hunt Scanlon Ventures

Hunt Scanlon Ventures is a leading M&A advisory firm focused exclusively on the global human capital market. The firm represents both buy-side and sell-side clients across a wide range of human capital verticals, including executive search, culture and leadership consulting, interim and on-demand talent solutions, RPO, HR technology, and executive coaching.

Hunt Scanlon Ventures advises strategic acquirers and private equity sponsors on their acquisition strategies while supporting founders and leadership teams seeking to exit, scale, or recapitalize. In addition to advisory services, Hunt Scanlon Ventures invests in top-tier talent platforms as a limited partner, often co-investing alongside venture capital managers in the sector.

Contact:

Drew Seaman

Managing Director

(602) 622-1392

[email protected] 

SOURCE Hunt Scanlon Ventures

Share this article

Patriot BTC Expected Initially to Hold Montana Data Center, Bitcoin Miners, Equipment and Related Infrastructure; Separation Intended to Create Focused Mining and AI Data Center Businesses

LAS VEGAS, Sept. 22, 2026 /PRNewswire/ -- Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence ("AI") data center company ("Hyperscale Data" or the "Company"), announced today that it is taking steps to form Patriot BTC, a proposed new subsidiary intended to hold the Company's cryptocurrency mining operations and related assets as a distinct business.

As part of the proposed transaction, Hyperscale Data intends to initially transfer all operating assets used in its cryptocurrency mining operations to Patriot BTC, including the Company's Montana data center, Bitcoin miners, mining equipment and related infrastructure.

The proposed transfer is intended to separate the Company's Bitcoin mining operations from its Michigan AI data center strategy. The Company believes the separation would align management attention and capital allocation with the distinct needs of each business, improve transparency into their respective operations and financial performance, and pave the way for the Michigan facility to operate as a standalone, single-purpose AI data center business.

Patriot BTC Mining Assets

Patriot BTC is intended to become a focused Bitcoin mining and infrastructure company that would generate its own Bitcoin through its mining operations. The Company currently anticipates that Patriot BTC will initially hold two principal groups of assets:

- The Company's Montana data center and related Montana assets and infrastructure; and

- The Company's Bitcoin miners, mining equipment and associated Bitcoin mining infrastructure.

By placing the mining assets within a dedicated subsidiary, Hyperscale Data believes Patriot BTC can provide greater transparency into the value, operations and financial performance of the Company's Bitcoin mining business.

Strategic Rationale and Alternatives for Patriot BTC

Management may recommend to the Board of Directors that, subject to applicable approvals, legal and regulatory requirements and other appropriate conditions, the Company pursue a transaction intended to position Patriot BTC within a publicly traded entity, whether through a separation or another transaction structure. The Company is evaluating potential structures to accomplish this objective and has not selected or approved a specific transaction structure.

Milton "Todd" Ault III, Executive Chairman of Hyperscale Data, stated, "Patriot BTC reflects our belief that the Company's Bitcoin mining business can create greater long-term value with a distinct identity, focused leadership and a strategy tailored to the digital asset sector. We believe greater focus and transparency will allow stockholders and the market to evaluate the mining business on its own merits."

Mr. Ault continued, "We continue to believe Bitcoin mining can be viable as a focused, single-purpose business. However, Bitcoin mining and AI data center development have different capital requirements, operating priorities and value drivers. Separating the businesses is intended to give each a clearer mandate and allow us to remain focused on positioning the Michigan facility for a potential sale, public-company transaction or internally funded development."

Under the proposed structure, Patriot BTC's management could focus on mining economics, fleet performance, power costs and related infrastructure, while the management of Alliance Cloud Services and Sentinum could focus on financing, developing and strategically positioning the Michigan AI data center.

Proposed Transaction

The formation of Patriot BTC has not yet been completed, and no transaction structure or separation involving Patriot BTC has been approved at this time.

Any proposed transaction involving Patriot BTC would be subject to, among other things:

- Approval by the Hyperscale Data Board of Directors;

- Applicable federal and state securities laws;

- Applicable NYSE American and other trading-market requirements;

- Tax and accounting considerations;

- Determination of the appropriate capitalization of Patriot BTC;

- Selection and implementation of an appropriate transaction structure; and

- Other legal, regulatory and business conditions deemed appropriate by the Company.

There can be no assurance that Patriot BTC will be formed as currently contemplated, that any proposed transaction involving Patriot BTC will be approved or completed, that Patriot BTC will become publicly traded, or as to the timing or final structure of any such transaction.

Hyperscale Data expects to provide additional information regarding Patriot BTC, including its capitalization, the final mining assets to be contributed, the proposed transaction structure and its anticipated trading and reporting structure, as those matters are determined and approved.

For more information on Hyperscale Data and its subsidiaries, Hyperscale Data recommends that stockholders, investors and any other interested parties read Hyperscale Data's public filings and press releases available under the Investor Relations section at hyperscaledata.com or available at www.sec.gov.

About Hyperscale Data, Inc.

Through its wholly owned subsidiary Sentinum, Inc., Hyperscale Data owns and operates a data center at which it offers colocation and hosting services for the emerging AI ecosystems and other industries. Another of Hyperscale Data's wholly owned subsidiaries, Ault Capital Group, Inc. ("ACG"), is a hybrid private equity firm and operating company that acquires, finances, builds and actively manages businesses across financial services, digital assets, industrial services, hospitality, defense technologies and other sectors.

Hyperscale Data currently expects the divestiture of ACG (the "Divestiture") to occur in 2027. Upon the occurrence of the Divestiture, the Company would be an owner and operator of data centers to support high-performance computing services, as well as a holder of the digital assets and the third wholly owned subsidiary of the Company, Omnipresent Robotics, LLC. Until the Divestiture occurs, the Company will continue to provide, through ACG and its wholly and majority-owned subsidiaries and strategic investments, mission-critical products that support a diverse range of industries, including an AI software platform, equipment rental services, defense/aerospace, industrial, automotive and hotel operations. In addition, ACG is actively engaged in private credit and structured finance through Ault Lending, LLC, a licensed lending subsidiary. Hyperscale Data's headquarters are located at 11411 Southern Highlands Parkway, Suite 190, Las Vegas, NV 89141.

On December 23, 2024, the Company issued one million (1,000,000) shares of a newly designated Series F Exchangeable Preferred Stock (the "Series F Preferred Stock") to all common stockholders and holders of the Series C Preferred Stock on an as-converted basis. The Divestiture will occur through the voluntary exchange of the Series F Preferred Stock for shares of Class A Common Stock and Class B Common Stock of ACG (collectively, the "ACG Shares"). The Company reminds its stockholders that only those holders of the Series F Preferred Stock who agree to surrender such shares, and do not properly withdraw such surrender, in the exchange offer through which the Divestiture will occur, will be entitled to receive the ACG Shares and consequently be shareholders of ACG upon the occurrence of the Divestiture.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "believes," "plans," "anticipates," "projects," "estimates," "expects," "intends," "strategy," "future," "opportunity," "may," "will," "should," "could," "potential," or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties.

Forward-looking statements speak only as of the date they are made, and the Company undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect the Company's business and financial results are included in the Company's filings with the U.S. Securities and Exchange Commission, including, but not limited to, the Company's Forms 10-K, 10-Q and 8-K. All filings are available at www.sec.gov and on the Company's website at hyperscaledata.com.

SOURCE Hyperscale Data Inc.

Share this article

Akto believes its placement reflects its platform approach across the full life cycle of agentic applications: discovery, automated AI red teaming, AI runtime controls and guardrails, and AI agent execution visibility.

SAN FRANCISCO, Sept. 22, 2026 /PRNewswire/ -- Akto, the leader in Agentic AI Security and MCP Security, today announced it has been named a Pioneer in the 2026 Gartner® Emerging Market Quadrant for AI Application Security — Startup Vendors.

According to the report, Gartner defines the AI application security market as "technologies that protect enterprise-developed AI applications and agents by combining security testing, exposure management, and runtime defense to detect, alert, or block threats. Delivered via SaaS or on-premises technologies, these tools enable cybersecurity and risk teams to manage posture, conduct adversarial testing, and enforce real-time protection of AI applications."

The report identifies three core capabilities that define the market: automated AI discovery and inventory, automated AI security testing, and AI runtime defense.

Pioneer status recognizes Akto as an AI Security vendor that shows architecturally advanced approaches across the full life cycle of agentic AI applications, spanning AI discovery and AI Security posture management, automated AI security testing, AI runtime defense, and supervision of agent actions, session-level behavior, and tool interactions.

In Akto's view, Gartner's introduction of a dedicated quadrant for AI security reflects the market's rapid commercial growth and rising enterprise demand. Recent incidents involving OpenAI and Hugging Face, along with a Google Gemini agent inadvertently accessing real-world company environments, demonstrate how quickly the scale and urgency of AI security and safety risks have intensified over the past few months.

"We're proud to see Akto recognized as a Pioneer in this very important emerging AI category by Gartner," said Ankita Gupta, CEO and Co-Founder of Akto. "Enterprises face security challenges on two fronts: adopting AI safely across their workforce and securely building AI applications and agents for their customers. Most organizations still lack the visibility and controls required to do either with confidence. Akto addresses the full breadth of this challenge through its two flagship products, Atlas and Argus. Fortune 1000 companies trust Akto's AI security control plane to discover, assess, govern, and protect AI across their environments."

Akto believes AI security is not a single control point but a continuous loop: discover what is running, test it, enforce policy at runtime, trace what happened, and feed that context back into governance. The platform delivers this in two products. Akto Atlas covers the governance of employee AI usage, helping security teams discover the AI apps, agents, MCP servers, skills, and plugins used across the workforce while applying runtime controls to those interactions. Akto Argus provides security for internally built AI applications and agents, with AI red teaming, runtime guardrails, AI Security gateway, MCP security controls, and execution visibility across agent activity.

Being named a Pioneer in Gartner EMQ adds to Akto's Gartner recognition across multiple areas of AI security. In 2026, Akto was also named a Sample Vendor for AI Security Testing in the Gartner Hype Cycle for AI Services, 2026; a Sample Vendor for AI Runtime Defense in the Gartner Hype Cycle for AI Governance, 2026; and a Sample Vendor for AI Runtime Defense in the Gartner Hype Cycle for Data Security Technologies, 2026. Akto was also named a Representative Vendor in Gartner's 2025 guide on securing AI agents.

Fortune 1000 organizations today trust Akto to confidently, securely, and safely adopt AI and build with AI.

Read more about the recognition here.

Gartner Disclaimer

Source: Gartner, Emerging Market Quadrant for AI Application Security — Startup Vendors, Meghan Hollis, Dionisio Zumerle, Dennis Xu, Marissa Schmidt, 16 September 2026, ID G00856640.

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner does not endorse any company, vendor, product or service depicted in its publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner publications consist of the opinions of Gartner's business and technology insights organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this publication, including any warranties of merchantability or fitness for a particular purpose.

About Akto

Akto is the leading Agentic AI Security platform, enabling enterprises to safely and securely adopt AI agents, MCPs, LLMs, and AI applications. The Akto platform provides continuous AI discovery, runtime guardrails, governance, AI security gateways, and automated red teaming, giving organizations a unified AI security control plane across their environments. Learn more at www.akto.io.

Media Contact: [email protected]

SOURCE Akto

Share this article